Surgery – Diagnostic testing – Measuring or detecting nonradioactive constituent of body...
Reexamination Certificate
2000-11-01
2003-02-11
Winakur, Eric F. (Department: 3736)
Surgery
Diagnostic testing
Measuring or detecting nonradioactive constituent of body...
C600S347000, C600S365000
Reexamination Certificate
active
06517482
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to non-invasive methods and devices for determining the level of glucose in a body fluid of a subject.
BACKGROUND OF THE INVENTION
There are numerous reasons for determining the level of glucose present in body fluid of a subject. In the case of a person suffering from diabetes, it is often necessary to determine the glucose level in blood daily, or even more frequently. Non-invasive approaches to determination of blood glucose levels have been suggested in the patent literature. For example, U.S. Pat. No. 5,036,861 (issued to Sembrowich et al. on Aug. 6, 1991) describes a wrist-mountable device having an electrode which measures glucose present in sweat at the skin surface. U.S. Pat. No. 5,222,496 (issued to Clarke et al. on Jun. 29, 1993) describes an infrared glucose sensor mountable, for instance, on a wrist or finger. U.S. Pat. No. 5,433,197 (issued to Stark on Jul. 18, 1995) describes determination of blood glucose through illuminating a patient's eye with near-infrared radiation. U.S. Pat. Nos. 5,115,133, 5,146,091 and 5,197,951 (issued to Knudson on May 19, 1992, Sep. 8, 1992 and Jan. 19, 1993, respectively) describe measuring blood glucose within blood vessels of a tympanic membrane in a human ear through light absorption measurements. The specifications of all of these patents are incorporated herein by reference.
The most common current approaches to determining blood glucose levels still appear to involve obtaining a sample of the person's blood and then measuring the level of glucose in the sample. These approaches will not be reviewed here except to say that obtaining the blood sample necessarily involves an invasive technique. Generally, the person's skin is broken or lanced to cause an external flow of blood which is collected in some fashion for the glucose level determination. This can be both inconvenient and distressful for a person and it is an object of the present invention to avoid the step of obtaining a blood sample directly, at least on a routine or daily basis.
It is known that skin tissue, when immersed in an aqueous glucose solution, equilibrates linearly with the concentration of external glucose (“Glucose entry into the human epidermis. I. The Concentration of Glucose in the Human Epidermis”, K. M. Halprin, A. Ohkawara and K. Adachi,
J. Invest. Dermatol.,
49(6): 559, 1967; “Glucose entry into the human epidermis. II. The penetration of glucose into the human epidermis in vitro”, K. M. Halprin and A. Ohkawara,
J. Invest. Derm.,
49(6): 561, 1967). It has also been shown that skin glucose can vary in synchrony with blood level glucose during standardized tolerance testing in vivo (“The cutaneous glucose tolerance test I. A rate constant formula for glucose disappearance from the skin”, R. M. Fusaro, J. A. Johnson and J. V. Pilsum,
J. Invest. Dermatol.,
42: 359, 1964; “The cutaneous glucose tolerance test”, R. M. Fusaro and J. A. Johnson,
J. Invest. Dermatol.,
44: 230, 1965). It is also known for equilibration of glucose levels to occur between blood and interstitial fluids in contact with blood vessels (“A microdialysis method allowing characterization of intercellular water space in human”, P. Lonnroth, P.-A. Jansson and U. Smith,
The American Journal of Physiology,
253 (Endocrinol. Metab., 16): E228-E231, 1987; “Assessment of subcutaneous glucose concentration; validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs,” U. Fischer, R. Ertle, P. Abel, K. Rebrin, E. Brunstein, H. Hahn von Dorsche and E. J. Freyse,
Diabetologia,
30: 940, 1987). Implantation of dialysis needles equipped with glucose sensors has shown that orally ingested glucose load is reflected by parallel changes in skin tissue glucose.
Radio frequency spectroscopy using spectral analysis for in vitro or in vivo environments is disclosed in WO 9739341 (published Oct. 23, 1997) and WO 9504496 (published Feb. 16, 1995). Measurement of a target chemical such as blood glucose is described.
SUMMARY OF THE INVENTION
The present invention is a method and apparatus for non-invasively monitoring levels of glucose in a body fluid of a subject. Typically, blood glucose levels are determined in a human subject.
In a preferred embodiment, the invention is a method for non-invasively monitoring glucose in a body fluid of a subject in which the method includes steps of measuring impedance between two electrodes in conductive contact with a skin surface of the subject and determining the amount of glucose in the body fluid based upon the measured impedance. Typically, the body fluid in which it is desired to know the level of glucose is blood. In this way, the method can be used to assist in determining levels of insulin administration.
The step of determining the amount of glucose can include comparing the measured impedance with a predetermined relationship between impedance and blood glucose level, further details of which are described below in connection with preferred embodiments.
In a particular embodiment, the step of determining the blood glucose level of a subject includes ascertaining the sum of a fraction of the magnitude of the measured impedance and a fraction of the phase of the measured impedance. The amount of blood glucose, in one embodiment, is determined according to the equation: Predicted glucose=(0.31)Magnitude+(0.24)Phase where the impedance is measured at 20 kHz.
In certain embodiments, impedance is measured at a plurality of frequencies, and the method includes determining the ratio of one or more pairs of measurements and determining the amount of glucose in the body fluid includes comparing the determined ratio(s) with corresponding predetermined ratio(s), i.e., that have been previously correlated with directly measured glucose levels.
In certain embodiments, the method of the invention includes measuring impedance at two frequencies and determining the amount of glucose further includes determining a predetermined index, the index including a ratio of first and second numbers obtained from first and second of the impedance measurements. The first and second numbers can include a component of said first and second impedance measurements, respectively. The first number can be the real part of the complex electrical impedance at the first frequency and the second number can be the magnitude of the complex electrical impedance at the second frequency. The first number can be the imaginary part of the complex electrical impedance at the first frequency and the second number can be the magnitude of the complex electrical impedance at the second frequency. The first number can be the magnitude of the complex electrical impedance at the first frequency and the second number can be the magnitude of the complex electrical impedance at the second frequency. In another embodiment, determining the amount of glucose further includes determining a predetermined index in which the index includes a difference between first and second numbers obtained from first and second of said impedance measurements. The first number can be the phase angle of the complex electrical impedance at the first frequency and said second number can be the phase angle of the complex electrical impedance at the second frequency.
The skin site can be located on the volar forearm, down to the wrist, or it can be behind an ear of a human subject. Typically, the skin surface is treated with a saline solution prior to the measuring step. An electrically conductive gel can be applied to the skin to enhance the conductive contact of the electrodes with the skin surface during the measuring step.
The electrodes can be in operative connection with a computer chip programmed to determine the amount of glucose in the body fluid based upon the measured impedance. There can be an indicator operatively connected to the computer chip for indication of the determined amount of glucose to the subject. The indicator can. provide a visual display to the subject.
In certain embodi
Elden Harry Richardson
Ollmar Stig
Wickett Randall R.
Dermal Therapy (Barbados) Inc.
Kremer Matthew
Pennie & Edmonds LLP
Winakur Eric F.
LandOfFree
Method and apparatus for non-invasive determination of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for non-invasive determination of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for non-invasive determination of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3119586